Harpreet Wasan

ORCID: 0000-0002-6268-2030

Also affiliated with Hammersmith Hospital, Imperial College London

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Encorafenib, Cetuximab, and mFOLFOX6 in BRAF -Mutated Colorectal Cancer”.

Encorafenib, Cetuximab, and mFOLFOX6 in BRAF -Mutated Colorectal Cancer

New England Journal of Medicine(2025)10.1056/nejmoa2501912

N/A

1.9DataRank · unranked

114 citations

Takayuki Yoshino, Lin Shen, Sara Lonardi, Eric Van Cutsem, Cathy Eng +15 more

Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial

Nature Medicine(2025)10.1038/s41591-024-03443-3

N/A

1.3DataRank · unranked

108 citations

Takayuki Yoshino, Eric Van Cutsem, Cathy Eng, Tae Won Kim, Harpreet Wasan +10 more